| DC zur Kennzeichnung von Arzdeibuchdrogen, 3. Mitt.: Direktaufgabe der Wirkstoffe von Drogen, die äther. Öle enthalten, mit dem TAS-Verfahren E Stahl, J Fuchs Dtsch. Apoth. Ztg. 108, 1227, 1968 | 37 | 1968 |
| TP-0903 is active in models of drug-resistant acute myeloid leukemia JY Jeon, DR Buelow, DA Garrison, M Niu, ED Eisenmann, KM Huang, ... JCI insight 5 (23), 2020 | 20 | 2020 |
| Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation RJ Tokarski II, CM Sharpe, AC Huntsman, BK Mize, OR Ayinde, EH Stahl, ... European Journal of Medicinal Chemistry 254, 115342, 2023 | 10 | 2023 |
| Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma GT Graham, SP Selvanathan, SK Zöllner, E Stahl, A Shlien, NJ Caplen, ... NAR cancer 4 (1), zcab052, 2022 | 6 | 2022 |
| Examination of the Impact of Triazole Position within Linkers on Solubility and Lipophilicity of a CDK9 Degrader Series OR Ayinde, C Sharpe, E Stahl, RJ Tokarski, JR Lerma, N Muthusamy, ... ACS Medicinal Chemistry Letters 14 (7), 936-942, 2023 | 1 | 2023 |
| Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia OA Elgamal, S Fobare, S Vibhute, A Mehmood, DC Vroom, ML Johnson, ... JCI insight 9 (8), 2024 | | 2024 |
| Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia S Fobare, OA Elgamal, M Wunderlich, E Stahl, A Mehmood, C Furby, ... Cancers 16 (3), 569, 2024 | | 2024 |
| A Novel Inhibitor of FLT3 and Its Drug-Resistant Mutants with Superior Activity to Gilteritinib in Molm-13 Preclinical Acute Myeloid Leukemia Xenograft Model OA Elgamal, JR Lerma, A Mullaney, E Stahl, B Stearns, A Orry, PCH Lam, ... Blood 140 (Supplement 1), 3352-3353, 2022 | | 2022 |
| Introducing a novel DHODH inhibitor with superior in vivo activity as monotherapy or in novel combination regimen with immunotherapy for hematological … OA Elgamal, S Vibhute, S Fobare, A Mehmood, ML Johnson, J Truxall, ... Cancer Research 82 (12_Supplement), 1060-1060, 2022 | | 2022 |
| EZH2 inhibition induces blast differentiation in acute myeloid leukemia S Fobare, OA Elgamal, EH Stahl, A Mehmood, J Truxall, ML Johnson, ... Cancer Research 82 (12_Supplement), 1824-1824, 2022 | | 2022 |
